Category Pharmaceuticals

Why did I sign the open letter in support of Pharmacare?

Wasem Alsabbagh shows that universal pharmacare is the natural product of the core values of Canada’s health care system and that it is cost-saving.

Request in Support of Universal Pharmacare

Since the 1960s, five national commissions have recommended universal pharmacare for Canada. The most recent of these is the detailed and strategic report of the Advisory Council on the Implementation of National Pharmacare. Now, after more than 50 years of waiting, Canada is close to adding prescription drugs to our “medicare” system. This is extremely […]

Conflicts of Interest: The case of Diclectin

Naila Ramji advocates for the importance of clinical trial transparency. 

Just Price for Drugs: The eleventh hour

Marc-André Gagnon urges modernization and fairness in the pricing of patented drugs in Canada

Monopolies on New Medicines & Trade with the U.S.

Deborah Gleeson and Ronald Labonté object to lengthening market exclusivity for biologic medicines in the United States-Mexico-Canada Agreement.